A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
Clinical trial NCT00243412 · COMPLETED
Trial details
- NCT number
- NCT00243412
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2009-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.